Escalon Medical Corp.
ESMC · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,231 | $2,400 | $1,186 | $931 |
| - Cash | $615,791 | $546 | $541 | $521 |
| + Debt | $237,298 | $523 | $516 | $329 |
| Enterprise Value | -$377,262 | $2,378 | $1,162 | $739 |
| Revenue | $2,675,321 | $2,570 | $3,474 | $3,221 |
| % Growth | 103,995.9% | -26% | 7.9% | – |
| Gross Profit | $1,120,742 | $1,124 | $1,600 | $1,574 |
| % Margin | 41.9% | 43.7% | 46.1% | 48.9% |
| EBITDA | -$227,378 | -$363 | $285 | $261 |
| % Margin | -8.5% | -14.1% | 8.2% | 8.1% |
| Net Income | -$239,852 | -$380 | $271 | $246 |
| % Margin | -9% | -14.8% | 7.8% | 7.6% |
| EPS Diluted | -0.03 | -0.028 | 0.018 | 0.02 |
| % Growth | -8.3% | -251.4% | -8.5% | – |
| Operating Cash Flow | $85,008 | $16 | $31 | $301 |
| Capital Expenditures | $0 | -$4 | $0 | $0 |
| Free Cash Flow | $85,008 | $12 | $31 | $301 |